Scarica l'app Stockscreener
0.9701
4.89%
-0.0499
Dopo l'orario di chiusura:
1.00
0.0299
+3.08%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Inovio Pharmaceuticals Inc Borsa (INO) Ultime notizie
Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
INO, MRNA, NVAX, EBS Jump Overnight: Trump Promises Full Hantavirus Report As Deadly Outbreak Sparks Vaccine Rally - Stocktwits
Correction: Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight - GlobeNewswire Inc.
Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch
INOVIO PHARMACEUTICALS, INC. SEC Filing (Jul 13, 2026) - Stock Titan
INO News | INOVIO PHARMACEUTICALS INC (NASDAQ:INO) - ChartMill
Inovio Pharmaceuticals (INO) Slips 3.36% as Stock Tests Near-Term SupportSmall Cap Breakouts - dars.gov.et
INO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Annou - The National Law Review
Inovio Pharmaceuticals updates investors on strategy as Nasdaq-listed biotech navigates a challengin - Ad Hoc News
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
INO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce - The National Law Review
INOInovio Pharmaceuticals Inc Volatility & Greeks - Finviz
Inovio stock leans on its pipeline. The market still wants proof. - ad-hoc-news.de
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Form S-3 Inovio Pharmaceuticals Inc For: 2 July By Investing.com - Investing.com Canada
INOVIO PHARMACEUTICALSMAY OFFER UP TO $300 MLN OF SECURITIESSEC FILING - Moomoo
Inovio Pharmaceuticals (NASDAQ: INO) files $300M shelf registration, notes BLA PDUFA - Stock Titan
INO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds - The National Law Review
Certain Restricted Stock Units of Inovio Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 2-JUL-2026. - marketscreener.com
INO STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Annou - The National Law Review
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Inovio Pharmaceuticals Inc. stock rises Monday, still underperforms market - MarketWatch
Inovio Pharmaceuticals, Inc.(NasdaqCM: INO) added to Russell 3000E Growth Benchmark - marketscreener.com
Inovio Pharmaceuticals, Inc.(NasdaqCM:INO) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Inovio Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:INO) - TradingView
Price to earnings forward of Inovio Pharmaceuticals, Inc. – NASDAQ:INO - TradingView
Price to sales forward of Inovio Pharmaceuticals, Inc. – NASDAQ:INO - TradingView
Enterprise value to revenue forward of Inovio Pharmaceuticals, Inc. – NASDAQ:INO - TradingView
Enterprise value to EBITDA forward of Inovio Pharmaceuticals, Inc. – NASDAQ:INO - TradingView
Inovio Pharmaceuticals, Inc. Actuals & Estimates (BX:GBM) - TradingView
Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
INO stock edges up after hours as partner reports success in cervical dysplasia trial - MSN
Inovio Pharmaceuticals, Inc. Actuals & Estimates (DUS:GBM) - TradingView
Inovio Pharmaceuticals, Inc. Actuals & Estimates (BMV:INO) - TradingView
INO Forecast — Price Target — Prediction for 2027 - TradingView
Inovio Pharmaceuticals Inc (INO) Institutional Confidence - TradingKey
Is Inovio Pharmaceuticals (INO) a High-Stakes Bet Ahead of its October PDUFA Date - Kavout | AI
0.46%
0.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):